Executive management from the 2019 Manny Award agency and network winners & finalists provide expert insight on healthcare industry topics and predictions.
For the twelfth year, Med Ad News chose new Marketing Ventures to Watch that could change the way pharma products are marketed and sold.
Med Ad News reached out to agency executives to get their perspectives on how they have dealt with gender and diversity issues in their careers and in their lives.
If there was one song that could be the pharma industry’s anthem during 2018-2019, it would be the David Bowie/Freddie Mercury hit “Under Pressure.” With the Trump administration’s and Congress’ efforts to reign in drug prices, pharma executives have a lot to keep them up at night.
Humira’s dominance continues as the world’s top-selling prescription product as the biologic therapy is the first drug to exceed $20 billion in annual global sales.
The return on R&D investment for leading biopharmaceutical manufacturers fell to a nine-year low while the U.S. FDA approved a record-breaking amount of novel medicines during 2018.
The Medical Advertising Hall of Fame honored 2019 inductees Carol DiSanto and Charlene Prounis on Feb. 7th at The Pierre in New York City.
The threatened “pharma marketing tax” may be back in play during 2019, at both the federal and state levels.
The U.S. Department of Health and Human Services (HHS) is considering proposing a plan that has many moving parts, one of which could potentially take the price that Medicare pays out to providers for Medicare Part B drugs and turn it on its head.
The talent and tenacity of immigrants can help drive the life sciences industry into the future, if we have the will and the wisdom to encourage it.